Quarterly report pursuant to Section 13 or 15(d)

4. Significant Strategic Collaborations (Details Narrative)

v3.20.2
4. Significant Strategic Collaborations (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
May 15, 2020
Research and Development Arrangement, Contract to Perform for Others [Line Items]          
Revenue $ 115,934 $ 0 $ 285,610 $ 0  
Takeda [Member] | Royalty [Member]          
Research and Development Arrangement, Contract to Perform for Others [Line Items]          
Revenue $ 116,000   $ 286,000    
Scripps Research [Member] | Scripps Agreement [Member]          
Research and Development Arrangement, Contract to Perform for Others [Line Items]          
Research commitment         $ 3,000,000